3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
36
Colorectal Neoplasms
17
Small Cell Lung Carcinoma
8
Neoplasms
8
Stomach Neoplasms
7
Neoplasm Metastasis
5
Sarcoma, Ewing
4
Rhabdomyosarcoma
4
Recurrence
4
Osteosarcoma
4
Biliary Tract Neoplasms
4
Rectal Neoplasms
3
Ovarian Neoplasms
3
Cholangiocarcinoma
3
Triple Negative Breast Neoplasms
2
Solid Tumor
2
Neuroblastoma
2
Nasopharyngeal Carcinoma
2
Metastatic Pancreatic Adenocarcinoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Wilms Tumor
1
Weight Loss
1
Somatostatinoma
1
Solid Tumor Cancer
1
Small Cell Lung Cancer Extensive Stage
1
Interventions
Oxaliplatin
11
Mitomycin
10
Leucovorin
7
Irinotecan
6
Fluorouracil
6
Hyperthermic Intraperitoneal Chemotherapy
5
Capecitabine
4
Surveys and Questionnaires
3
Cytoreduction Surgical Procedures
3
Cisplatin
3
dehydroftorafur
2
Trastuzumab
2
Thalidomide
2
Mitozytrex
2
Melphalan
2
Interleukin-12 Subunit p35
2
Floxuridine
2
Doxorubicin
2
Cetuximab
2
Biopsy
2
tipifarnib
1
surufatinib
1
sodium thiosulfate
1
sintilimab
1
nintedanib
1
nilotinib
1
motexafin lutetium
1
irinotecan sucrosofate
1
entinostat
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Appendiceal Neoplasms
×
irinotecan sucrosofate
×
Clear all
NCT05277766
2025-07-01
PIPAC-NAL-IRI
University Hospital, Ghent
Phase 1
Recruiting
45 enrolled